BD to provide injection devices for mass doses of COVID-19 vaccines

By The Science Advisory Board staff writers

July 8, 2020 -- Becton Dickinson (BD) formed a strategic partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop new manufacturing lines for injection devices that will provide the U.S. government with hundreds of millions of syringes and needles to support pandemic vaccination efforts.

Under the partnership, BARDA will invest $42 million to further expand BD's operations and manufacturing capacity in Nebraska. The total capital investment will be $70 million. The new capacity is expected to be online within 12 months and once completed BARDA will have priority access to injection devices.

BD has also agreed to supply 50 million needles and syringes to be delivered by the end of December 2020 to support COVID-19 vaccination efforts in the U.S. This order will be fulfilled through BD's current manufacturing capacity and will support Operation Warp Speed.

Moreover, the Defense Production Act designation on the initial order enables BD to seek priority access to raw materials for manufacturing, and the company also expects enhanced logistics support from the U.S. government to ensure rapid transport and distribution.

BARDA awards supply contract to Regeneron for COVID-19 cocktail
Regeneron Pharmaceuticals was awarded a $450 million contract to manufacture and supply its REGN-COV2 antibody cocktail that is currently in phase...
SiO2 increases vial capacity for COVID-19 vaccines
Advanced materials company SiO2 Materials Science has increased the manufacturing capacity of its plastic medical-grade vials to help meet the demand...
U.S. launches project to promote pharma manufacturing
The U.S. Department of Health and Human Services on May 19 announced a new project to promote U.S.-based pharmaceutical manufacturing to secure the supply...
BARDA gives $20M to Sabin Vaccine Institute for vaccines
The U.S. Biomedical Advanced Research and Development Authority (BARDA) awarded the Sabin Vaccine Institute $20 million to manufacture and release...
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter